Visual Acuity Outcomes of Ranibizumab Treatment in Pathologic Myopic Eyes With Macular Retinoschisis and Choroidal Neovascularization

Retina - United States
doi 10.1097/iae.0000000000001236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Visual Acuity in 3422 Consecutive Eyes With Choroidal Nevus

Archives of Ophthalmology
2007English

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated With Ranibizumab

Turk Oftalmoloiji Dergisi
Ophthalmology
2017English

Prognostic Factors for Visual Outcomes 2-Years After Intravitreal Bevacizumab for Myopic Choroidal Neovascularization

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2011English

Characteristics of Eyes With Secondary Loss of Visual Acuity Receiving Variable Dosing Ranibizumab for Neovascular Age-Related Macular Degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Two Different Initial Treatment Regimens of Ranibizumab in Myopic Choroidal Neovascularization: 12-Month Results From a Randomized Controlled Study

Clinical and Experimental Ophthalmology
MedicineOphthalmology
2018English

Features Associated With Foveal Retinal Detachment in Myopic Macular Retinoschisis

American Journal of Ophthalmology
Ophthalmology
2010English

Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration

BMC Ophthalmology
MedicineOphthalmology
2016English

Association Between Choroidal Morphology and Anti-Vascular Endothelial Growth Factor Treatment Outcome in Myopic Choroidal Neovascularization

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Choroidal Neovascularization in 36 Eyes of Children and Adolescents

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy